Filing Details
- Accession Number:
- 0001722482-20-000174
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-08 19:09:40
- Reporting Period:
- 2020-12-04
- Accepted Time:
- 2020-12-08 19:09:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1722482 | Avantor Inc. | AVTR | Laboratory Analytical Instruments (3826) | 822758923 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1776153 | Michael Stubblefield | Radnor Corporate Center, Building One, Suite 200, 100 Matsonford Road Radnor PA 19087 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-12-04 | 880,601 | $1.60 | 2,147,536 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-12-04 | 412,188 | $27.08 | 1,735,348 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-12-07 | 210,369 | $1.60 | 1,945,717 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-12-07 | 98,452 | $27.45 | 1,847,265 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2020-12-04 | 880,601 | $0.00 | 880,601 | $1.60 |
Common Stock | Stock Options (Right to Buy) | Disposition | 2020-12-07 | 201,369 | $0.00 | 201,369 | $1.60 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
201,369 | 2024-05-12 | No | 4 | M | Direct | |
0 | 2024-05-12 | No | 4 | M | Direct |
Footnotes
- The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan.
- Reflects shares sold to cover the Reporting Person's exercise price and tax liability in connection with the exercise of stock options.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $26.77 to $27.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.24 to $27.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- These options are fully vested.